J

Jeisys Medical Inc
KOSDAQ:287410

Watchlist Manager
Jeisys Medical Inc
KOSDAQ:287410
Watchlist
Price: 12 900 KRW 0.16% Market Closed
Market Cap: 976.4B KRW
Have any thoughts about
Jeisys Medical Inc?
Write Note
Section:
 

Relative Value

The Relative Value of one Jeisys Medical Inc stock under the Base Case scenario is 17 413.87 KRW. Compared to the current market price of 12 900 KRW, Jeisys Medical Inc is Undervalued by 26%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

Relative Value
Base Case
17 413.87 KRW
Undervaluation 26%
Relative Value
Price
J
Worst Case
Base Case
Best Case

Valuation Multiples

5.8
P/S
P/S
Price to Sales
5.8
vs History
38
vs Industry
18
Median 3Y
5.8
Median 5Y
5.6
Industry
2.3
Forward
5
More Details
34.8
P/E
P/E
Price to Earnings
34.8
vs History
33
vs Industry
14
Median 3Y
30.2
Median 5Y
30.2
Industry
23.1
Forward
23
More Details
32.5
P/OCF
P/OCF
Price to OCF
32.5
vs History
44
vs Industry
13
Median 3Y
26.5
Median 5Y
32.5
Industry
14.2
More Details
15.5
P/FCFE
P/FCFE
Price to FCFE
15.5
vs History
87
vs Industry
16
Median 3Y
34.8
Median 5Y
45.4
Industry
20.1
More Details
8.7
P/B
P/B
Price to Book Value
8.7
vs History
39
vs Industry
5
Median 3Y
8.7
Median 5Y
8.6
Industry
2.2
More Details
5.7
EV/S
EV/S
Enterprise Value to Sales
5.7
vs History
36
vs Industry
17
Median 3Y
5.7
Median 5Y
5.4
Industry
2.4
Forward
5
More Details
8.2
EV/GP
EV/GP
Enterprise Value to Gross Profit
8.2
vs History
38
vs Industry
21
Median 3Y
8.2
Median 5Y
7.8
Industry
5
More Details
22.5
EV/EBITDA
EV/EBITDA
Enterprise Value to EBITDA
22.5
vs History
17
vs Industry
14
Median 3Y
19.2
Median 5Y
18.1
Industry
12.7
Forward
16.4
More Details
25.2
EV/EBIT
EV/EBIT
Enterprise Value to EBIT
25.2
vs History
17
vs Industry
17
Median 3Y
21.3
Median 5Y
19.7
Industry
17.1
Forward
17.8
More Details
32.1
EV/OCF
EV/OCF
Enterprise Value to OCF
32.1
vs History
25
vs Industry
14
Median 3Y
25.5
Median 5Y
25.9
Industry
14
More Details
98.1
EV/FCFF
EV/FCFF
Enterprise Value to FCFF
98.1
vs History
11
vs Industry
15
Median 3Y
38.2
Median 5Y
38.7
Industry
18
More Details
8
EV/IC
EV/IC
Enterprise Value to IC
8
vs History
77
vs Industry
6
Median 3Y
8.8
Median 5Y
11
Industry
1.9
More Details

Multiples Across Competitors

Competitors Multiples
Jeisys Medical Inc Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
KR
Jeisys Medical Inc
KOSDAQ:287410
974B KRW 5.8 34.8 22.5 25.2
US
Abbott Laboratories
NYSE:ABT
199B USD 4.8 34.5 20 29.3
US
Intuitive Surgical Inc
NASDAQ:ISRG
191.3B USD 24.3 85.3 72.8 90.4
US
Stryker Corp
NYSE:SYK
141.3B USD 6.4 39.4 25.6 31
US
Boston Scientific Corp
NYSE:BSX
134.2B USD 8.4 74.8 34.3 49
IE
Medtronic PLC
NYSE:MDT
104.6B USD 3.2 24.4 13.6 19.3
US
Becton Dickinson and Co
NYSE:BDX
65.6B USD 3.3 38 15.7 28.2
DE
Siemens Healthineers AG
XETRA:SHL
58.1B EUR 2.6 31.2 17.7 25.8
US
Edwards Lifesciences Corp
NYSE:EW
44.5B USD 7.9 10.7 23.8 26.1
CN
Shenzhen Mindray Bio-Medical Electronics Co Ltd
SZSE:300760
307.8B CNY 8.3 24.9 21.6 21.6
US
GE Healthcare Technologies Inc
NASDAQ:GEHC
36.3B USD 1.9 21.6 13.6 16.7

See Also

Summary
Intrinsic value, competitors valuation, and company profile.
DCF Valuation
Stock valuation using Discount Cash Flow valuation method.
Relative Valuation
Stock valuation using valuation multiples.
Wall Street Estimates
Price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
Stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Back to Top
ALPHA SPREAD
Follow us
Join more than 211,100+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.